RBC Capital Reiterates Outperform Rating on Abbott Labs (ABT), 'dips create opportunity'
Tweet Send to a Friend
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $147.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
